EP Patent

EP3384911A4 — PHARMACEUTICAL COMPOSITION CONTAINING 2- {4- [N- (5,6-DIPHENYLPYRAZIN-2-YL) -N-ISOPROPYLAMINO] BUTYLOXY} -N- (METHYLSULFONYL) ACETAMIDE

Assigned to Nippon Shinyaku Co Ltd · Expires 2019-05-15 · 7y expired

What this patent protects

Patent listed against Uptravi.

Drugs covered by this patent

Patent Metadata

Patent number
EP3384911A4
Jurisdiction
EP
Classification
—
Expires
2019-05-15
Drug substance claim
No
Drug product claim
No
Assignee
Nippon Shinyaku Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.